List View List View   Icon View Icon View

Showing items 1 - 9 of 9.

Add to Quick Collection   All 9 Results

  • First
  • Previous
  • 1
  • Next
  • Last
Title Author/Creator Date Full Text Reviewed
Add Apoptosis of human melanoma cells induced by inhibition of B-RAFᵛ⁶⁰⁰ᴱ involves preferential splicing of bimS Jiang, C. C.; Lai, F.; Zhang, X. D.; Tay, K. H.; Croft, A.... More 2010 — Reviewed
Add Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIPL from degradation by the E3 ligase itch in human melanoma cells Yang, F.; Tay, K. H.; Zhang, X. D.; Dong, L.; Thorne, R. F.... More 2010 — Reviewed
Add Biomarkers in melanoma Gogas, H.; Eggermont, A. M. M.; Hauschild, A.; Hersey, P.; Mohr, P.... More 2009 Full Text Reviewed
Add Immunotherapy of distant metastatic disease Schadendorf, D.; Algarra, S. M.; Schachter, J.; Hersey, P.; Bastholt, L.... More 2009 — Reviewed
Add O⁶-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib Watson, A. J.; Middleton, M. R.; Haydon, A.; Kefford, R.; Lorigan, P.... More 2009 — Reviewed
Add Small molecules and targeted therapies in distant metastatic disease Hersey, P.; Bastholt, L.; Schadendorf, D.; Chiarion-Sileni, V.; Cinat, G.... More 2009 Full Text Reviewed
Add Societal preference values for advanced melanoma health states in the United Kingdom and Australia Beusterien, K. M.; Szabo, S. M.; Kotapati, S.; Mukherjee, J.; Hoos, A.... More 2009 — Reviewed
Add Utility of adjuvant systemic therapy in melanoma Eggermont, A. M. M.; Testori, A.; Marsden, J.; Hersey, P.; Quirt, I.... More 2009 — Reviewed
Add Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma Hersey, P.; Halliday, G. M.; Farrelly, M. L.; DeSilva, C.; Lett, M.... More 2008 Full Text Reviewed
  • First
  • Previous
  • 1
  • Next
  • Last
Author/Creator
Keyword